TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Local Injury to the Endometrium for Implantation and Pregnancy Rates in ICSI -ET Cycles With Recurrent Implantation Failure: a Randomised Controlled Study
Brief Summary: Objective To evaluate the effect of local injury to the endometrium for implantation, pregnancy and live birth rates in ICSI -ET cycles with recurrent implantation failure.

Design Randomized controlled clinical study. Setting A clinical will assist reproductive center of Selcuk University Meram Medical Faculty Hospital in the Konya, Turkey.

Population A group of 100 women, who failed to conceive during one or more cycles of IVF and embryo transfer (ET), will treat with a long protocol for controlled ovarian hyperstimulation.

Methods The IVF treatment and ET will precede by repeated endometrial biopsies, in a randomly selected 50 of a total of 100 women.


Options:
A: Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): N/A
B: Arm Label: Control - Standard ART treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Test - PGS; Type: EXPERIMENTAL; Interventions: Genetic: Next Generation Sequencing after Blastocyst biopsy | Intervention Type: GENETIC; Name: Next Generation Sequencing after Blastocyst biopsy; Assigned to Arm(s): Test - PGS
C: Arm Label: PGS (genetic screening); Type: EXPERIMENTAL; Interventions: Diagnostic Test: Preimplantation Genetic Screening | Arm Label: no PGS (no genetic screening); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIAGNOSTIC_TEST; Name: Preimplantation Genetic Screening; Assigned to Arm(s): PGS (genetic screening)
D: Arm Label: Endometrial injury group; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial injury | Arm Label: Control group; Type: SHAM_COMPARATOR; Interventions: Procedure: Control group | Intervention Type: PROCEDURE; Name: Endometrial injury; Assigned to Arm(s): Endometrial injury group | Intervention Type: PROCEDURE; Name: Control group; Assigned to Arm(s): Control group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Local Injury to the Endometrium for Implantation and Pregnancy Rates in ICSI -ET Cycles With Recurrent Implantation Failure: a Randomised Controlled Study
Brief Summary: Objective To evaluate the effect of local injury to the endometrium for implantation, pregnancy and live birth rates in ICSI -ET cycles with recurrent implantation failure.

Design Randomized controlled clinical study. Setting A clinical will assist reproductive center of Selcuk University Meram Medical Faculty Hospital in the Konya, Turkey.

Population A group of 100 women, who failed to conceive during one or more cycles of IVF and embryo transfer (ET), will treat with a long protocol for controlled ovarian hyperstimulation.

Methods The IVF treatment and ET will precede by repeated endometrial biopsies, in a randomly selected 50 of a total of 100 women.


Options:
A: Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): N/A
B: Arm Label: Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal saline | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): Placebo
C: Arm Label: local ingury; Type: ACTIVE_COMPARATOR; Interventions: Procedure: local injury | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: local injury; Assigned to Arm(s): local ingury
D: Arm Label: Endometrial biopsy arm; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial biopsy, Device: Transvaginal ultrasound | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): Endometrial biopsy arm | Intervention Type: DEVICE; Name: Transvaginal ultrasound; Assigned to Arm(s): Endometrial biopsy arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Educational Program With Telephone Follow-up for Patients After Percutaneous Coronary Intervention: Randomized Controlled Trial
Brief Summary: The purpose of this study is to elaborate an educative program that includes telephone follow-up and assess its impact on the perceived health status of patients submitted to percutaneous coronary intervention.


Options:
A: Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: educational program+telephone follow up; Type: EXPERIMENTAL; Interventions: Behavioral: educational program+telephone follow up | Intervention Type: BEHAVIORAL; Name: educational program+telephone follow up; Assigned to Arm(s): educational program+telephone follow up | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): usual care
B: Arm Label: THA Physiotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: THA Physiotherapy, Procedure: No physiotherapy after THA | Arm Label: No physiotherapy after THA; Type: ACTIVE_COMPARATOR; Interventions: Procedure: No physiotherapy after THA | Intervention Type: PROCEDURE; Name: THA Physiotherapy; Assigned to Arm(s): THA Physiotherapy | Intervention Type: PROCEDURE; Name: No physiotherapy after THA; Assigned to Arm(s): No physiotherapy after THA, THA Physiotherapy
C: Arm Label: Audio Relaxation technique; Type: EXPERIMENTAL; Interventions: Behavioral: Audio Relaxation Technique | Arm Label: Medical Music Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Medical Music Intervention | Arm Label: Nature Therapy without Music; Type: EXPERIMENTAL; Interventions: Behavioral: Nature Therapy without Music | Arm Label: Nature Therapy with Music; Type: EXPERIMENTAL; Interventions: Behavioral: Nature Therapy with Music | Intervention Type: BEHAVIORAL; Name: Audio Relaxation Technique; Assigned to Arm(s): Audio Relaxation technique | Intervention Type: BEHAVIORAL; Name: Medical Music Intervention; Assigned to Arm(s): Medical Music Intervention | Intervention Type: BEHAVIORAL; Name: Nature Therapy without Music; Assigned to Arm(s): Nature Therapy without Music | Intervention Type: BEHAVIORAL; Name: Nature Therapy with Music; Assigned to Arm(s): Nature Therapy with Music
D: Arm Label: etomidate/sevoflurane; Type: ACTIVE_COMPARATOR; Interventions: Other: control, Other: suggestion, Other: dreamfilm | Arm Label: propofol/sevoflurane; Type: ACTIVE_COMPARATOR; Interventions: Other: control, Other: suggestion, Other: dreamfilm | Arm Label: propofol/propofol; Type: ACTIVE_COMPARATOR; Interventions: Other: control, Other: suggestion, Other: dreamfilm | Intervention Type: OTHER; Name: control; Assigned to Arm(s): etomidate/sevoflurane, propofol/propofol, propofol/sevoflurane | Intervention Type: OTHER; Name: suggestion; Assigned to Arm(s): etomidate/sevoflurane, propofol/propofol, propofol/sevoflurane | Intervention Type: OTHER; Name: dreamfilm; Assigned to Arm(s): etomidate/sevoflurane, propofol/propofol, propofol/sevoflurane

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Educational Program With Telephone Follow-up for Patients After Percutaneous Coronary Intervention: Randomized Controlled Trial
Brief Summary: The purpose of this study is to elaborate an educative program that includes telephone follow-up and assess its impact on the perceived health status of patients submitted to percutaneous coronary intervention.


Options:
A: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational Reminder | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Educational Reminder | Intervention Type: BEHAVIORAL; Name: Educational Reminder; Assigned to Arm(s): Control, Intervention
B: Arm Label: usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: educational program+telephone follow up; Type: EXPERIMENTAL; Interventions: Behavioral: educational program+telephone follow up | Intervention Type: BEHAVIORAL; Name: educational program+telephone follow up; Assigned to Arm(s): educational program+telephone follow up | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): usual care
C: Arm Label: Stress reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Transcendental Meditation | Arm Label: health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health Education | Intervention Type: BEHAVIORAL; Name: Transcendental Meditation; Assigned to Arm(s): Stress reduction | Intervention Type: BEHAVIORAL; Name: Health Education; Assigned to Arm(s): health education
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: education | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: education; Assigned to Arm(s): A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 2 Week Single Blind Study to Evaluate Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease
Brief Summary: To determine the amount of phosphate recovered into 2 strengths of K2CG chewing gum in a modified formulation (with or without an extender) added to the gum core, in comparison to matching placebo gums.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Niacinamide | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Niacinamide; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Arm Label: Placebo 20mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: Placebo 60mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Intervention Type: OTHER; Name: chewing gum; Assigned to Arm(s): K2CG 20mg, K2CG 20mg extender, K2CG 60 mg, K2CG 60 mg extender, Placebo 20mg, Placebo 60mg
C: Arm Label: Sevelamer; Type: EXPERIMENTAL; Interventions: Drug: Sevelamer | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Sevelamer; Assigned to Arm(s): Sevelamer | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Renal Function Group #1; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #2; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #3; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #4; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #5; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #6; Type: N/A; Interventions: N/A | Arm Label: Renal Function Group #7; Type: N/A; Interventions: N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A 2 Week Single Blind Study to Evaluate Phosphate Binding of Chitosan Chewing Gum in Patients With Chronic Kidney Disease
Brief Summary: To determine the amount of phosphate recovered into 2 strengths of K2CG chewing gum in a modified formulation (with or without an extender) added to the gum core, in comparison to matching placebo gums.


Options:
A: Arm Label: Placebo 20mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 60 mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg extender; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: K2CG 20mg; Type: ACTIVE_COMPARATOR; Interventions: Other: chewing gum | Arm Label: Placebo 60mg; Type: PLACEBO_COMPARATOR; Interventions: Other: chewing gum | Intervention Type: OTHER; Name: chewing gum; Assigned to Arm(s): K2CG 20mg, K2CG 20mg extender, K2CG 60 mg, K2CG 60 mg extender, Placebo 20mg, Placebo 60mg
B: Arm Label: HS219; Type: EXPERIMENTAL; Interventions: Dietary Supplement: HS219 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: HS219; Assigned to Arm(s): HS219 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Arm Label: Calcium Carbonate (Phosphate Binder); Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: 1500 mg/d elemental calcium as calcium carbonate | Intervention Type: DIETARY_SUPPLEMENT; Name: 1500 mg/d elemental calcium as calcium carbonate; Assigned to Arm(s): Calcium Carbonate (Phosphate Binder) | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: dietary education | Intervention Type: BEHAVIORAL; Name: dietary education; Assigned to Arm(s): A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia
Brief Summary: This research study is designed to test the use of ranolazine in patients with angina (chest discomfort due to reduced blood supply to the heart) due to microvascular coronary dysfunction (MCD; abnormalities in the small blood vessels of the heart). This drug is approved by the U.S. Food and Drug Administration (FDA) for treatment of chronic angina. The FDA has approved this drug based on studies primarily on patients with chronic angina with major blockages of the arteries.


Options:
A: Arm Label: Ranolazine; Type: EXPERIMENTAL; Interventions: Drug: Ranolazine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ranolazine; Assigned to Arm(s): Ranolazine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Ranolazine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ranolazine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Ranolazine placebo | Arm Label: Ranolazine; Type: EXPERIMENTAL; Interventions: Drug: Ranolazine, Drug: Ranolazine placebo | Intervention Type: DRUG; Name: Ranolazine; Assigned to Arm(s): Ranolazine | Intervention Type: DRUG; Name: Ranolazine placebo; Assigned to Arm(s): Placebo, Ranolazine
D: Arm Label: Study Drug Ranexa, Then Placebo; Type: EXPERIMENTAL; Interventions: Drug: Ranolazine, Drug: Placebo | Arm Label: Placebo, Then Study Drug Ranexa(Ranolazine); Type: EXPERIMENTAL; Interventions: Drug: Ranolazine, Drug: Placebo | Intervention Type: DRUG; Name: Ranolazine; Assigned to Arm(s): Placebo, Then Study Drug Ranexa(Ranolazine), Study Drug Ranexa, Then Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo, Then Study Drug Ranexa(Ranolazine), Study Drug Ranexa, Then Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Follow up After Self-poisoning by General Practitioner- a Randomised Clinical Trial
Brief Summary: The study hypothesis is that follow up from general practitioner after hospitalization for self poisoning will decrease suicidal behaviour.


Options:
A: Arm Label: Psychosocial group intervention; Type: EXPERIMENTAL; Interventions: Behavioral: 10 weekly group meetings, Behavioral: Outpatient counseling and support groups | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Outpatient counseling and support groups | Intervention Type: BEHAVIORAL; Name: 10 weekly group meetings; Assigned to Arm(s): Psychosocial group intervention | Intervention Type: BEHAVIORAL; Name: Outpatient counseling and support groups; Assigned to Arm(s): Control, Psychosocial group intervention
B: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up
C: Arm Label: NMDA receptor antagonist; Type: ACTIVE_COMPARATOR; Interventions: Drug: NMDA receptor antagonist (active drug) | Arm Label: Placebo tablet; Type: PLACEBO_COMPARATOR; Interventions: Other: Lactose packed capsule (inert/inactive arm) | Intervention Type: DRUG; Name: NMDA receptor antagonist (active drug); Assigned to Arm(s): NMDA receptor antagonist | Intervention Type: OTHER; Name: Lactose packed capsule (inert/inactive arm); Assigned to Arm(s): Placebo tablet
D: Arm Label: Fluoxetine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluoxetine, Drug: Citalopram | Arm Label: Dialectical behavior therapy; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: DBT | Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): Fluoxetine | Intervention Type: BEHAVIORAL; Name: DBT; Assigned to Arm(s): Dialectical behavior therapy | Intervention Type: DRUG; Name: Citalopram; Assigned to Arm(s): Fluoxetine

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Follow up After Self-poisoning by General Practitioner- a Randomised Clinical Trial
Brief Summary: The study hypothesis is that follow up from general practitioner after hospitalization for self poisoning will decrease suicidal behaviour.


Options:
A: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up
B: Arm Label: SB-APP Psychotherapy; Type: EXPERIMENTAL; Interventions: Other: SB-APP | Arm Label: TAU treatment; Type: ACTIVE_COMPARATOR; Interventions: Other: treatment as usual | Intervention Type: OTHER; Name: SB-APP; Assigned to Arm(s): SB-APP Psychotherapy | Intervention Type: OTHER; Name: treatment as usual; Assigned to Arm(s): TAU treatment
C: Arm Label: dynamic deconstructive psychotherapy; Type: EXPERIMENTAL; Interventions: Behavioral: Psychodynamic Therapy | Arm Label: optimized community care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Optimized Community Care | Intervention Type: BEHAVIORAL; Name: Psychodynamic Therapy; Assigned to Arm(s): dynamic deconstructive psychotherapy | Intervention Type: BEHAVIORAL; Name: Optimized Community Care; Assigned to Arm(s): optimized community care
D: Arm Label: Brief Admission; Type: EXPERIMENTAL; Interventions: Other: Brief Admission | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Brief Admission; Assigned to Arm(s): Brief Admission

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Follow up After Self-poisoning by General Practitioner- a Randomised Clinical Trial
Brief Summary: The study hypothesis is that follow up from general practitioner after hospitalization for self poisoning will decrease suicidal behaviour.


Options:
A: Arm Label: Telephone-based management; Type: EXPERIMENTAL; Interventions: Behavioral: Treatment as Usual | Arm Label: iFightDepression for Suicide; Type: EXPERIMENTAL; Interventions: Behavioral: Treatment as Usual | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Telephone-based management, Behavioral: iFightDepression for Suicide | Arm Label: Self Awareness of Mental Health; Type: EXPERIMENTAL; Interventions: Behavioral: Treatment as Usual, Behavioral: Self Awareness of Mental Health | Intervention Type: BEHAVIORAL; Name: Telephone-based management; Assigned to Arm(s): Treatment as Usual | Intervention Type: BEHAVIORAL; Name: iFightDepression for Suicide; Assigned to Arm(s): Treatment as Usual | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Self Awareness of Mental Health, Telephone-based management, iFightDepression for Suicide | Intervention Type: BEHAVIORAL; Name: Self Awareness of Mental Health; Assigned to Arm(s): Self Awareness of Mental Health
B: Arm Label: Peer Mentorship intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer mentorship | Arm Label: Enhanced Usual Care (EUC); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Peer mentorship; Assigned to Arm(s): Peer Mentorship intervention | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): Enhanced Usual Care (EUC)
C: Arm Label: ASAP Treatment and Brite; Type: EXPERIMENTAL; Interventions: Behavioral: As Safe As Possible, Behavioral: Brite | Arm Label: Treatment as Usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Treatment as Usual | Intervention Type: BEHAVIORAL; Name: As Safe As Possible; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Brite; Assigned to Arm(s): ASAP Treatment and Brite | Intervention Type: BEHAVIORAL; Name: Treatment as Usual; Assigned to Arm(s): Treatment as Usual
D: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Follow up After Self-poisoning by General Practitioner- a Randomised Clinical Trial
Brief Summary: The study hypothesis is that follow up from general practitioner after hospitalization for self poisoning will decrease suicidal behaviour.


Options:
A: Arm Label: Interventional group; Type: EXPERIMENTAL; Interventions: Other: Usual treatment and Prevention program | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Treatment | Intervention Type: OTHER; Name: Usual treatment and Prevention program; Assigned to Arm(s): Interventional group | Intervention Type: OTHER; Name: Usual Treatment; Assigned to Arm(s): Control group
B: Arm Label: Youth-Nominated Support Team; Type: EXPERIMENTAL; Interventions: Behavioral: Youth-Nominated Support Team | Arm Label: Enhanced Treatment as Usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Youth-Nominated Support Team; Assigned to Arm(s): Youth-Nominated Support Team
C: Arm Label: Dialectical behavior therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Arm Label: alternative psychotherapy; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Dialectical behavior therapy (DBT) | Intervention Type: BEHAVIORAL; Name: Dialectical behavior therapy (DBT); Assigned to Arm(s): Dialectical behavior therapy, alternative psychotherapy
D: Arm Label: Follow up; Type: EXPERIMENTAL; Interventions: Behavioral: Follow up | Arm Label: Usual Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Follow up; Assigned to Arm(s): Follow up

Answer: D